What is the recommended dose of co-amoxiclav (amoxicillin/clavulanic acid) 312.5/5ml preparation for a 9-year-old child weighing 35kg with a suspected bacterial infection and no known allergy to penicillin?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 31, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Co-Amoxiclav Dosing for a 9-Year-Old Child (35kg) with Suspected Bacterial Infection

For a 9-year-old child weighing 35kg with suspected bacterial infection, administer 10 ml of the 312.5mg/5ml preparation (250mg amoxicillin/62.5mg clavulanate per 5ml) three times daily, providing 750mg amoxicillin per dose or 2250mg total daily. 1

Age-Based Dosing Algorithm

The 312.5mg/5ml preparation is specifically the 250/62 suspension formulation, which is indicated for children aged 7-12 years. 1 This formulation provides:

  • 250mg amoxicillin + 62.5mg clavulanate per 5ml
  • Standard dose: 5ml three times daily for children 7-12 years 1
  • For a 35kg child, this provides approximately 21 mg/kg/day of amoxicillin component 1

When High-Dose Therapy is Required

However, if this child has ANY of the following risk factors, you must use the high-dose regimen (90 mg/kg/day) instead: 1, 2

  • Age <2 years (not applicable here)
  • Daycare attendance 1
  • Recent antibiotic use within past 30 days 1, 2
  • Incomplete Haemophilus influenzae type b vaccination 1
  • Geographic area with >10% penicillin-resistant S. pneumoniae 1
  • Moderate to severe illness 1
  • Concurrent purulent acute otitis media 1

For high-dose therapy (90 mg/kg/day): 1

  • This 35kg child requires 3150mg amoxicillin daily (1575mg twice daily)
  • The 250/62 suspension cannot achieve this dose practically
  • You would need approximately 31.5ml twice daily of the 250/62 suspension, which is impractical
  • Switch to a higher concentration formulation or use tablets to achieve proper dosing 1

Critical Dosing Verification Steps

Before dispensing, verify: 1

  1. Confirm the exact suspension concentration - the 312.5mg/5ml designation suggests 250mg amoxicillin + 62.5mg clavulanate per 5ml 1
  2. Assess for risk factors requiring high-dose therapy 1, 2
  3. Maximum daily dose: Do not exceed 4000mg amoxicillin per day regardless of weight 1, 3

Treatment Duration and Monitoring

  • Standard duration: 10 days for most bacterial respiratory infections 1, 4
  • Clinical improvement expected within 48-72 hours 1, 2
  • If no improvement by 72 hours: Reevaluate diagnosis, consider atypical pathogens, assess for complications, or switch antibiotics 1, 2

Common Pitfalls to Avoid

The most critical error is using standard-dose therapy when high-dose is indicated. 1 This leads to:

  • Treatment failure with resistant organisms 1
  • Inadequate tissue concentrations 1
  • Promotion of antimicrobial resistance 1

The second major pitfall is miscalculating the suspension concentration. 1 Always verify whether you have 125/31 or 250/62 suspension before calculating volume, as dosing errors are common when providers assume the wrong concentration. 1

Adverse Effects

Common adverse effects include: 1, 5

  • Diarrhea (occurs in approximately 25% vs 15% placebo) 5
  • Nausea and vomiting 1
  • Rash 1
  • The 14:1 ratio formulation (used in high-dose therapy) causes less diarrhea than other amoxicillin-clavulanate preparations 1

References

Guideline

Amoxicillin-Clavulanate Dosing in Pediatric Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Treatment of Respiratory Infections in Vulnerable Infants

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Amoxicillin Dosing Guidelines for Pediatric Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Beginning antibiotics for acute rhinosinusitis and choosing the right treatment.

Clinical reviews in allergy & immunology, 2006

Related Questions

When to use amoxicillin (amoxicillin) versus amoxicillin-clavulanate (amoxicillin-clavulanic acid) for treating infections?
What is the recommended dose of Amoxiclav (amoxicillin/clavulanic acid) syrup in mL for a 1-year-old child weighing 9.58 kg?
What is the recommended dose of Augmentin (amoxicillin/clavulanic acid) for a patient weighing 29.2 pounds?
What is the recommended dosage of Amoclavin 457 (amoxicillin/clavulanic acid) for a child weighing 36 kg?
What is the recommended dose of Amoxil (amoxicillin) for a 14kg child with a lower respiratory tract infection?
What is the recommended dose of co-amoxiclav (amoxicillin/clavulanic acid) for a 9-year-old, 35 kg child with a suspected bacterial infection and no penicillin allergy, based on common suspension preparations?
What is the appropriate management for a patient with joint pain and swelling, elevated inflammatory markers (C-Reactive Protein (CRP) and Erythrocyte Sedimentation Rate (ESR)), hypercalcemia, and impaired renal function (elevated creatinine and reduced estimated Glomerular Filtration Rate (eGFR))?
What is the best course of treatment for a patient with a 1-year-old chronic wound to the lateral malleolus, measuring 1x1 cm with a depth of 0.2 cm, covered in adherent yellow slough, and surrounded by erythema, who has previously used silver alginate and silicone foam dressings?
What is the recommended use and dosage of Cangrelor (generic name) for patients undergoing percutaneous coronary intervention (PCI) who are at high risk for thrombotic events and have not received a P2Y12 inhibitor prior to the procedure?
What is the typical medical management approach for a patient with coronary artery disease, a history of angina, and potentially low hemoglobin levels, requiring a blood transfusion?
What is the mechanism of action of terlipressin in patients with hepatorenal syndrome?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.